(Total Views: 269)
Posted On: 03/26/2021 7:36:15 AM
Post# of 36519
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
30 days ago - “We are preparing our IND submission for Phase I and II human clinical trials to evaluate safety and immunogenicity of the Ii-Key vaccine, and plan to submit the IND to the FDA as soon as the GMP production of the Ii-Key vaccine is completed in the coming weeks."
We should be just about there for the following items:
IND submission
Expected 8K
China / Malaysia update
Nasdaq NGIO
We should be just about there for the following items:
IND submission
Expected 8K
China / Malaysia update
Nasdaq NGIO
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)